Abstract
Abstract PR-007: Patient-derived immunocompetent cultures reveal personalized immunotherapies and new treatment options for therapy resistant patients with high-grade serous ovarian cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have